Ikonisys S.A. (9W8)

Overview

Ikonisys S.A., established in 2021, is a cell-based diagnostics company that plays a significant role in the medical diagnostics industry, particularly focusing on cancer diagnostics. With operations both in the United States and Europe, the company specializes in the design, manufacturing, marketing, and sale of innovative medical diagnostic products. Its main objective is to advance cancer diagnostics through automation, precision, and accessibility, offering cutting-edge solutions that leverage the latest in cellular analysis technology.

Products and Services

• Ikoniscope Robotic Microscope: This advanced system streamlines the diagnostic process by offering automated slide handling, scanning, and real-time image capture and analysis. It is designed to improve efficiency and accuracy in laboratory settings.
• oncoFISH bladder: A diagnostic tool designed for the scanning and analysis of cells recovered from voided urine samples. This application aids in the early detection and monitoring of bladder cancer.
• oncoFISH her2: A microscopy application specialized for the determination of HER2 status in tissue sections from breast tissue biopsies. This is crucial for identifying the appropriate treatment plan for breast cancer patients.
• oncoFISH anaplastic lymphoma kinase (ALK): This application utilizes FISH (Fluorescence In Situ Hybridization) for the detection of rearrangements in the gene encoding anaplastic lymphoma kinase (ALK), relevant in certain types of non-small cell lung cancer.
• oncoFISH PTEN: A microscopy application for the FISH-based detection of deletions in the PTEN gene within prostate tissue biopsies. This is important for prostate cancer diagnosis and understanding tumor behavior.
• Circulating Tumor Cells: This technology facilitates the characterization of individual tumor cells, providing insights into the behavior and characteristics of various cancers.
• Circulating Tumor DNA (ctDNA): Offers global tumor genotype information, which is crucial for understanding the genetic makeup of tumors and tailor treatment plans accordingly.
• Ikonisoft Explorer CS: A FISH scanning application designed for the analysis of cell suspension deposited on a slide, which has been hybridized with a combination of FISH probes. This application is versatile for different types of cellular analyses.
• Ikonisoft Explorer Tissue: Similar to the Explorer CS, this application is focused on the analysis of various tissue sections hybridized with a chosen combination of FISH probes, providing detailed insights into tissue-specific cancers.
• IkoniWAN Gateway: A validated remote access solution that allows for the remote operation of Ikoniscope digital microscopy systems. This technological innovation enhances the accessibility and efficiency of cancer diagnostics by enabling pathologists and researchers to access and analyze samples from anywhere.